Oncology: Brain Tumor
Although brain and spine tumors represent 20% of all solid tumors, there is nothing routine about them. Each patient requires personalized care depending on the biology of his or her particular tumor. At the Gill Center, our Brain Tumor Program provides patients with a multidisciplinary approach to personalized care, a depth of expertise and a commitment to research.
We treat 80 to 100 new patients a year. Each week, new patients and those with progressive tumors are presented at a weekly tumor board. A core strength of our program, the board works together to confirm diagnoses and develop comprehensive treatment plans. This team comprises oncologists, neurologists, neurosurgeons, pathologists and neuro-radiologists, rounded out by ophthalmologists, endocrinologists, a physician assistant, nurses, child life specialists, psychologists and physical, speech and occupational therapists.
- Diagnose between 80 and 100 new patients with brain or spine tumors each year.
- Treat benign and malignant tumors of the brain and spine, including astrocytoma, brainstem glioma, ependymoma and medulloblastoma.
- Offering enrollment in clinical studies approved by the National Cancer Institute, the Children’s Oncology Group and UT Southwestern.
- Robust research through Brain Tumor Survivor Program focuses on premature aging phenomenon and metabolism
- Program Director Daniel Bowers, M.D., is a leading expert in pediatric brain tumor treatment and survivorship. He serves on the Children’s Oncology Group Brain Tumor Steering Committee and leads the consortium’s Neurological Task Force for Survivorship and Outcomes Committee.